» Articles » PMID: 32920321

Effects of Cerebellar Transcranial Magnetic Stimulation on Ataxias: A Randomized Trial

Overview
Specialty Neurology
Date 2020 Sep 13
PMID 32920321
Citations 20
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: Cerebellar ataxia remains a neurological symptom orphan of treatment interventions, despite being prevalent and incapacitating. We aimed to study, in a double-blind design, whether cerebellar modulation could improve ataxia.

Methods: We included patients with diagnosis of spinocerebellar ataxia type 3, multiple systems atrophy cerebellar type, or post-lesion ataxia. Patients received five sessions each of sham and active cerebellar 1 Hz deep repetitive transcranial magnetic stimulation in randomized order. Our primary outcome was the decrease in the Scale for the Assessment and Rating of Ataxia when comparing phases (active x sham). Secondary outcomes measures included the International Cooperative Ataxia Rating Scale, and other motor, cognitive, and quality of life scales. This study was registered at clinicaltrials.gov (protocol NCT03213106).

Results: Twenty-four patients aged 29-74 years were included in our trial. After active stimulation, the Scale for the Assessment and Rating of Ataxia score was significantly lower than the score after sham stimulation [median (interquartile range) of 10.2 (6.2, 16.2) versus 12.8 (9.6, 17.8); p = 0.002]. The International Cooperative Ataxia Rating Scale score also improved after active stimulation versus sham [median (interquartile range) of 29.0 (21.0, 43.5) versus 32.8 (22.0, 47.0); p = 0.005]. Other secondary outcomes were not significantly modified by stimulation. No patient presented severe side effects, and nine presented mild and self-limited symptoms.

Conclusions: Our protocol was safe and well-tolerated. These findings suggest that cerebellar modulation may improve ataxic symptom and provide reassurance about safety for clinical practice.

Citing Articles

Effects of Non-Invasive Brain Stimulation for Degenerative Cerebellar Ataxia: A Systematic Review and Meta-Analysis.

Matsugi A, Ohtsuka H, Bando K, Kondo Y, Kikuchi Y Mov Disord Clin Pract. 2024; 11(11):1323-1334.

PMID: 39221650 PMC: 11542298. DOI: 10.1002/mdc3.14205.


Effects of cerebellar repetitive transcranial magnetic stimulation plus physiotherapy in spinocerebellar ataxias - A randomized clinical trial.

Grobe-Einsler M, Bork F, Faikus A, Hurlemann R, Kaut O CNS Neurosci Ther. 2024; 30(6):e14797.

PMID: 38887169 PMC: 11183922. DOI: 10.1111/cns.14797.


Clinical neurophysiology in the treatment of movement disorders: IFCN handbook chapter.

Lefaucheur J, Moro E, Shirota Y, Ugawa Y, Grippe T, Chen R Clin Neurophysiol. 2024; 164:57-99.

PMID: 38852434 PMC: 11418354. DOI: 10.1016/j.clinph.2024.05.007.


Item performance of the scale for the assessment and rating of ataxia in rare and ultra-rare genetic ataxias.

Hamdan A, Hooker A, Chen X, Traschutz A, Schule R, Synofzik M CPT Pharmacometrics Syst Pharmacol. 2024; 13(8):1327-1340.

PMID: 38769902 PMC: 11330187. DOI: 10.1002/psp4.13162.


Content Validity of the Modified Functional Scale for the Assessment and Rating of Ataxia (f-SARA) Instrument in Spinocerebellar Ataxia.

Potashman M, Rudell K, Pavisic I, Suminski N, Doma R, Heinrich M Cerebellum. 2024; 23(5):2012-2027.

PMID: 38713312 PMC: 11489265. DOI: 10.1007/s12311-024-01700-2.